Let’s engage.

A phase 1/2 study to evaluate the safety, tolerability, and preliminary...

June 13, 2022 / 0 Minute Read

New Therapy Options for Neuroendocrine Carcinoma of the Pancreas—The Emergent Substance...

June 9, 2022 / 0 Minute Read

Metabolism-based GP-2250 in combination with gemcitabine as a novel approach to...

March 30, 2022 / 0 Minute Read

Innovative substance 2250 as a highly promising anti-neoplastic agent in malignant...

July 13, 2017 / 0 Minute Read

Innovative substance 2250, a derivative of taurultam, shows anti-neoplastic effects in...

February 13, 2016 / 0 Minute Read

[ajax_load_more posts_per_page="9" pause="true" offset="10" scroll="false" images_loaded="true" button_label="Load More"]